Survey and assessment of mammalian estrogen biological assays for hazard characterization

Fundamental and Applied Toxicology

Volumn 34, Issue 2, 1996, Pages 288-305

  Reel, Jerry R ^a   Lamb IV, James C ^b   Neal, Barbara H ^b  

^a BIOQUAL INC   (United States)

^b Jellinek Schwartz and C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PROLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; BREAST CANCER; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DETERMINATION; ESTROGEN ACTIVITY; FEMALE; GENITAL SYSTEM; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HYPOPHYSIS CELL; INTERMETHOD COMPARISON; KERATINIZATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TARGET ORGAN; TECHNIQUE; TRANSCRIPTION REGULATION; UTERUS WEIGHT; VAGINA EPITHELIUM;

EID: 26844495001     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0198     Document Type: Article

References (105)

1. Allen, E., and Doisy, E. A. (1923). An ovarian hormone. Preliminary report on its localization, extraction and partial purification, and action in test animals. J. Am. Med. Assoc. 81, 819-821.
2. Allen, E., and Doisy, E. A. (1924). The induction of a sexually mature condition in immature females by injection of the ovarian follicular hormone. Am. J. Physiol. 69, 577-588.
3. Astwood, E. B. (1938). A six-hour assay for the quantitative determination of estrogen. Endocrinology 23, 25-31.
4. Auger, J., Kunstmann, J. M., Czylik, F., and Jouannet, P. (1995). Decline in semen quality among fertile men in Paris during the past 20 years. N. Engl. J. Med. 332, 281-285.
5. Bennett, J. P., and Vickery, B. H. (1970). Rats and mice. In Reproduction and Breeding Techniques for Laboratory Animals (E. S. E. Hafez, Ed.), Chap. 17, pp. 299-316. Lea and Febiger, Philadelphia.
6. Biggers, J. D. (1951). Observations on the intravaginal assay of natural oestrogens using aqueous egg albumin as the vehicle of administration. J. Endocrinol. 7, 163-171.
7. Biggers, J. D., and Claringbold, P. J. (1954). Criteria of the vaginal response to oestrogens. J. Endocrinol. 11, 277-284.
8. Bitman, J., and Cecil, H. C. (1970). Estrogenic activity of DDT analogs and polychlorinated biphenyls. J. Agr. Food Chem. 18, 1108-1112.
9. Bitman, J., Cecil, H. C., Mench, M. L., and Wrenn, T. R. (1965). Kinetics of in vivo glycogen synthesis in the estrogen-stimulated rat uterus. Endocrinology 76, 63-69.
10. Bondy, K. L., and Zacharewski, T. R. (1993). ICI 164, 384: A control for investigating estrogen responsive genes. Nucleic Acids Res. 21, 5277-5278.
11. Bowden, R. T., Hissom, J. R., and Moore, M. R. (1989). Growth stimulation of T47D human breast cancer cells by the anti-progestin RU486. Endocrinology 124, 2642-2644.
12. Branham, W. S., and Sheehan, D. M. (1995). Ovarian and adrenal contributions to postnatal growth and differentiation of the rat uterus. Biol. Reprod. 53, 863-872.
13. Branham, W. S., Zehr, D. R., Chen, J. J., and Sheehan, D. M. (1988). Postnatal uterine development in the rat: Estrogen and antiestrogen effects on luminal epithelium. Teratology 38, 29-36.
14. Branham, W. S., Zehr, D. R., and Sheehan, D. M. (1988). Differential sensitivity of rat uterine growth and epithelium hypertrophy to estrogens and antiestrogens. Proc. Soc. Exp. Biol. Med. 203, 297-303.
15. Brooks, S. C., Locke, E. R., and Soule, H. (1973). Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J. Biol. Chem. 248, 6251-6253.
16. Bretons, J. A., Olea-Serrano, M. F., Vilalobos, M., Pedraza, V., and Olea, N. (1995). Xenoestrogens released from lacquer coatings in food cans. Environ. Health Perspect. 103, 608-612.
17. Bulbring, E., and Burn, J. H. (1935). The estimation of oestrin and of male hormone in oily solution. J. Physiol. 85, 320-333.
18. Burrows, H. (1949). Biological Actions of Sex Hormones, 2nd ed. Cambridge Univ. Press, London.
19. Chapin, R. E., Stevens, J. T., Hughes, C. L., Kelce, W. R., Hess, R. A., and Daston, G. P. (1996). Endocrine modulation of reproduction. Fundam. Appl. Toxicol. 29, 1-17.
20. Clark, J. H., and Mani, S. K. (1994). Actions of ovarian steroid hormones, In The Physiology of Reproduction (E. Knobil and J. D. Neill, Eds.), 2nd ed., Chap. 17, pp. 1011-1059. Raven Press, New York.
21. Colborn, T., vom Saal, F. S., and Soto, A. M. (1993). Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 101, 378-384.
22. Coppola, J. A., and Perrine, J. W. (1965). Influence of two nonsteroidal antiestrogens on vaginal opening and PMS-induced ovulation in rats. Endocrinology 76, 865-869.
23. Davis, E. L., Bradlow, H. L., Wolff, M., Woodruff, T., Hoel, D. G., and Anton-Culver, H. (1993). Medical hypothesis: Xenoestrogens as preventable causes of breast cancer. Environ. Health Perspect. 101, 372-377.
24. Desaulniers, D. M., Leingartner, K., Stoddart, K., and Foster, W. G. (1995). Development of an in vitro bioassay to assess the estrogenic potential of xenobiotics using cloned and wild-type MCF-7 cells. Biol. Reprod. 52(Suppl. 1), 170. [Abstract 456]
25. Dorfman, R. I., and Dorfman, A. S. (1954). Estrogen assays using the rat uterus. Endocrinology 55, 65-69.
26. Dorfman, R. I., Gallagher, T. F., and Koch, F. C. (1936). The nature of the estrogenic substance in human male urine and bull testis. Endocrinology 19, 33-41.
27. Dorfman, R. I., and Kinel, F. A. (1966). Uterotrophic activity of various phenolic steroids. Acta Endocrinol. 52, 619-626.
28. Eckstein, P., Krohn, P. L., Zuckerman, S., and Healy, M. J. R. (1952). The comparative potency of natural and synthetic oestrogens in the rhesus monkey. J. Endocrinol. 8, 291-307.
29. Edgren, R. A. (1994). Issues in animal pharmacology. In Pharmacology of the Contraceptive Steroids (J. W. Goldzieher, Ed.), pp. 81-97. Raven Press, New York.
30. Edgren, R. A., Jones, R. C., and Peterson, D. L. (1967). The estrogenic effects of a series of 13β-substituted compounds related to estradiol-17β. Eur. J. Steroids. 2, 19-31.
31. Edgren, R. A., Peterson, D. L, Jones, R. C., Nagra, C. L., Smith, H., and Hughes, G. A. (1966). Biological effects of synthetic gonanes. Rec. Prog. Horm. Res. 22, 305-349.
32. Emmens, C. W. (1942). The differentiation of oestrogens from pro-oestrogens by the use of spayed mice possessing two separate vaginal sacs. J. Endocrinol. 3, 174-177.
33. Emmens, C. W. (1950a). The intravaginal assay of naturally occurring oestrogens. J. Endocrinol 6, 302-307.
34. Emmens, C. W. (1950b). Estrogens. In Hormone Assay (C. W. Emmens, Ed.), Chap. XVI, pp. 391-417. Academic Press, New York.
35. Emmens, C. W. (1962). Estrogens. In Methods in Hormone Research, Vol. II, Bioassay (R. I. Dorfman, Ed.), Chap. 2, pp. 59-111. Academic Press, New York.
36. Emmens, C. W., and Martin, L. (1964). Estrogens. In Methods in Hormone Research, Vol. III, Steroidal Activity in Experimental Animals and Man, Part A (R. I. Dorfman, Ed.), Chap. 1, pp. 1-80. Academic Press, New York.
37. Eroschenko, V. P., and Cooke, P. S. (1990). Morphological and biochemical alterations in reproductive tracts of neonatal female mice treated with the pesticide methoxychlor. Biol. Reprod. 42, 573-583.
38. Evans, J. S., Varney, R. F., and Koch, F. C. (1941). The mouse uterine weight method for the assay of estrogens. Endocrinology 28, 747-752.
39. Finney, D. J. (1978). Statistical Method in Biological Assay, 3rd ed. Charles Griffin, London.
40. Folman, Y., and Pope, G. S. (1966). The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency. J. Endocrinol. 34, 215-225.
41. Galand, P., Mairesse, N., Degraef, C., and Rooryck, J. (1987). o.p'DDT (1,1,1-trichloro-2(p-chlorophenyl) 2-(o-chlorophenyl) ethane is a purely estrogenic agonist in the rat uterus in vivo and in vitro. Biochem. Pharmacol. 36, 397-400.
42. Guillette, L. J., Jr., Gross, T. S., Masson, G. R., Matter, J. M., Percival, H. F., and Woodward, A. R. (1994). Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. Environ. Health Perspect. 102, 680-688.
43. Hisaw, F. L., Jr. (1959). Comparative effectiveness of estrogens on fluid imbibition and growth of the rat's uterus. Endocrinology 64, 276-289.
44. Hisaw, F. L., Mischler, T. W., and Kroc, R. L. (1971). Estrogenic properties of quinestrol and estradiol-17β in the ovariectomized rhesus monkey. Proc. Soc. Exp. Biol. Med. 137, 43-46.
45. Ireland, J. S., Mukku, V. R., Robison, A. K., and Stancel, G. M. (1980). Stimulation of uterine deoxyribonucleic acid synthesis by 1, 1, 1-trichloro-2-(p-chlorophenyl)-2-(o-chlorophenyl) ethane (o,p'-DDT). Biochem. Pharmacol. 29, 1469-1474.
46. Jeng, M.-H., and Jordan, V. C. (1991). Growth stimulation and differential regulation of transforming growth factor-β1(TGFβ1), TGFβ2, and TGFβ3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells. Mol. Endocrinol. 5, 1120-1128.
47. Jeng, M.-H., Langan-Fahey, S. M., and Jordan, V. C. (1993). Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells. Endocrinology 132, 2622-2630.
48. Jeng, M.-H., Parker, C. J., and Jordan, V. C. (1992). Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation. Cancer. Res. 52, 6539-6546.
49. Jensen, E. V., and Jacobson, H. I. (1960). Fate of steroid estrogens in target tissue. In Biological Activities of Steroids in Relation to Cancer (G. Pincus and E. P. Vollmer, Eds.), pp. 161-178. Academic Press, New York.
50. Jobling, S., Reynolds, T., White, R., Parker, M. G., and Sumpter, J. P. (1995). A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ. Health Perspect. 103, 582-587.
51. Jones, R. C., and Edgren, R. A. (1973). The effects of various steroids on the vaginal histology in the rat. Fertil. Steril. 24, 284-291.
52. Jordan, V. C., Mittal, S., Gosden, B., Koch, R., and Lieberman, M. E. (1985). Structure-activity relationships of estrogens. Environ. Health Perspect. 61, 97-110.
53. Kahnt, L. C., and Doisy, E. A. (1928). The vaginal smear method of assay of the ovarian hormone. Endocrinology 12, 760-768.
54. Kasis, J. A., Sakai, D., Walent, J. H., and Gorski, J. (1984). Primary cultures of estrogen-responsive cells from rat uteri: Induction of progesterone receptors and a secreted protein. Endocrinology 114, 1558-1566.
55. Kendra, K. L., and Katzenellenbogen, B. S. (1987). An evaluation of the involvement of polyamines in modulating MCF-7 human breast cancer cell proliferation and progesterone receptor levels by estrogen and antiestrogen. J. Steroid Biochem. 28, 123-128.
56. Klein, K. O., Baron, J., Colli, M. J., McDonnell, D. P., and Cutler Jr., G. B., (1994). Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J. Clin. Invest. 94, 2475-2480.
57. Klein, K. O., Demers, L. M., Santner, S. J., Baron, J., Cutler Jr., G. B., and Santen, R. J. (1995). Use of ultrasensitive recombinant cell bioassay to measure estrogen levels in women with breast cancer receiving the aromatase inhibitor, letrozole. J. Clin. Endocrinol. Metab. 80, 2658-2660.
58. Krohn, P. L. (1956). The administration of oestrogens and progesterone to monkeys. J. Endocrinol. 14, xii-xv.
59. Kronenberg, M. S., and Clark, J. H. (1985). Changes in keratin expression during the estrogen-mediated differentiation of rat vaginal epithelium. Endocrinology 117, 1480-1489.
60. Lamb, J. C., IV (1989). Design and use of multigeneration breeding studies for identification of reproductive toxicants. In Toxicology of the Male and Female Reproductive Systems (P. K. Working, Ed.), Chap. 5, pp. 131-155. Hemisphere, New York.
61. Lancet Editorial (1995). Male reproductive health and environmental oestrogens. Lancet 345, 933-935.
62. Lauson, H. D., Heller, C. G., Golden, J. B., and Sevringhaus, E. L. (1939). The immature rat uterus in the assay of estrogenic substances, and a comparison of estradiol, estrone and estriol. Endocrinology 24, 35-44.
63. Lerner, L. J. (1964). Hormone antagonists: Inhibitors of specific activities of estrogen and androgen. Rec. Prog. Horm. Res. 20, 435-490.
64. Lieberman, M. E., Gorski, J., and Jordan, V. C. (1983a). An estrogen receptor model to describe the regulation of prolactin synthesis by antiestrogens in vitro. J. Biol. Chem. 258, 4741-4745.
65. Lieberman, M. E., Jordan, V. C., Fritsch, M., Santos, M. A., and Gorski, J. (1983b). Direct and reversible inhibition of estradiol-stimulated prolactin synthesis by antiestrogen in vitro. J. Biol. Chem. 258, 4734-4740.
66. Lieberman, M. E., Maurer, R. A., and Gorski, J. (1978). Estrogen control of prolactin synthesis in vitro. Proc. Natl. Acad. Sci. USA 75, 5946-5949.
67. Lippman, M. (1981). Hormonal regulation of human breast cancer cells in vitro. Banbury Rep. 8, 171-184.
68. Lippman, M., Bolan, G., and Huff, K. (1976). The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer. Res. 36, 4595-4601.
69. Lippman, M., Monaco, M. E., and Bolan, G. (1977). Effects of estrone, estradiol, and estriol on hormone-responsive human breast cancer in long-term tissue culture. Cancer. Res. 37, 1901-1907.
70. MacMahon, B. (1994). Pesticide residues and breast cancer? J. Natl. Cancer Inst. 86, 572-573.
71. Markaverich, B. M., Webb, B., Densmore, C. L., and Gregory, R. R. (1995). Effects of coumestrol on estrogen receptor function and uterine growth in ovariectomized rats. Environ. Health Perspect. 103, 574-581.
72. Martin, L. (1960). The use of 2,3,5-triphenyltetrazolium chloride in the biological assay of oestrogens. J. Endocrinol 20, 187-197.
73. Martin, L., and Claringbold, P. J. (1958). A highly sensitive assay for oestrogens. Nature 181, 620-621.
74. Martin, L., and Claringbold, P. J. (1960). The mitogenic action of oestrogens in the vaginal epithelium of the ovariectomized mouse. J. Endocrinol. 20, 173-186.
75. Mayr, U., Butsch, A., and Schneider, S. (1992). Validation of two in vitro test systems for estrogenic activities with zearalenone, phytoestrogens, and cereal extracts. Toxicology 74, 135-149.
76. McDonnell, D. P., Nawaz, Z., Densmore, C., Weigel, N. L., Pham, T. A., Clark, J. H., and O'Malley, B. W. (1991). High level expression of biologically active estrogen receptor in Saccharomyces cerevisiae. J. Steriod Biochem. Mol. Biol. 39, 291-297.
77. McLachlan, John A. (1993). Functional toxicology: A new approach to detect biologically active xenobiotics. Environ. Health Perspect. 101, 386-387.
78. Miksicek, R. J. (1993). Commonly occurring plant flavonoids have estrogenic activity. Mol. Pharmacol. 44, 37-43.
79. Nagel, S. C., Taylor, J. A., vomSaal, F. S., and Welshons, W. V. (1995a). Relative binding affinity-serum enhanced access assay to predict the estrogenic bioactivity of phytoestrogens and alkylphenols. The Endocrine Society Abstracts, p. 227. [Abstract 457]
80. Nagel, S. C., Thayer, K. A., Boechler, M., Dhar, M., Morellini, F., Taylor, J. A., vomSaal, F. S., and Welshons, W. V. (1995b). An in vitro assay to predict the in vivo activity of environmental estrogens. Biol. Reprod. 52(Suppl. 1), 96. [Abstract 159]
81. Obourn, J. D., Koszewski, N. J., and Notides, A. C. (1993). Hormone-and DNA-binding mechanisms of the recombinant human estrogen receptor. Biochemistry 32, 6229-6236.
82. Patterson, R. M., Selkirk, J. K., and Merrick, B. A. (1995). Baculovirus and insect cell gene expression: Review of baculovirus biotechnology. Environ. Health Perspect. 103, 756-759.
83. Prophet User's/Statistics Manual, Release 3.1 (August, 1990). Prepared by Bolt Beranek and Newman, Inc., 10 Moulton Street, Cambridge, MA 02138 [(617) 873-2669]. Prepared for National Center for Research Resources, National Institutes of Health, Bethesda, MD. Licensed to the U.S. Government under Contract No. N01-RR-5-2112 in accordance with HHSAR Clause No. 352.227-1 "Rights in Data (April, 1984)" at CFR 3.
84. Reel, J. R., Humphrey, R. R., Shih, Y.-H., Windsor, B. L., Sakowski, R., Creger, P. L., and Edgren, R. A. (1979). Competitive progesterone antagonists: Receptor binding and biologic activity of testosterone and 19-nortestosterone derivatives. Fertil. Steril. 31, 552-561.
85. Robson, J. M., and Adler, J. (1940). Site of action of oestrogens. Nature 146, 160.
86. Rubin, B. L., Dorfman, A. S., Black, L., and Dorfman, R. I. (1951). Bioassay of estrogens using the mouse uterine response. Endocrinology 49, 429-439.
87. Safe, S. H. (1994). Dietary and environmental estrogens and antiestrogens and their possible role in human disease. Environ. Sci. Pollut. Res. 1, 29-33.
88. Schane, H. P., Anzalone, A. J., and Potts, G. O. (1972). A model for the evaluation of estrogens: Withdrawal bleeding in ovariectomized rhesus monkeys. Fertil. Steril 23, 745-750.
89. Sharpe, R. M., and Skakkebaek, N. E. (1993). Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341, 1392-1395.
90. Sherins, R. J. (1995). Are semen quality and male fertility changing? N. Engl. J. Med. 332, 327-328.
91. Smith, D. E. (1967). Location of the estrogen effect on uterine glucose metabolism. Proc. Soc. Exp. Biol. Med. 124, 747-749.
92. Smith, D. E., and Gorski, J. (1968). Estrogen control of uterine glucose metabolism. J. Biol Chem. 243(16), 4169-4174.
93. Smith, D. E., and Stultz, M. S. (1971). Properties of estrogen-sensitive uterine sugar metabolism: Specificity of inhibitory sugars. Endocrinology 88, 218-223.
94. Soto, A. M., Chung, K. L., and Sonnenschein, C. (1994). The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environ. Health Perspect. 102, 380-383.
95. Soto, A. M., Justicia, H., Wray, J. E., and Sonnenschein, C. (1991). p-Nonyl-phenol: An estrogenic xenobiotic released from "modified" polystyrene. Environ. Health Perspect. 92, 167-173.
96. Soto, A. M., Lin, T.-M., Justica, H., Silvia, R. M., and Sonnenschein, C. (1992). An "in culture" bioassay to assess the estrogenicity of xenobiotics (E-screen). In Advances in Modern Environmental Toxicology. Chemically Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection, Vol. 21, pp. 295-309. Princeton Sci. Pub., Princeton.
97. Soto, A. M., and Sonnenschein, C. (1984). Mechanism of estrogen action on cellular proliferation: Evidence for indirect and negative control on cloned breast tumor cells. Biochem. Biophys. Res. Commun. 122, 1097-1103.
98. Soto, A. M., and Sonnenschein, C. (1985). The role of estrogens on the proliferation of human breast tumor cells (MCF-7). J. Steroid Biochem. 23, 87-94.
99. Soule, H. D., Vazquez, J., Long, A., Albert, S., and Brennan, M. (1973). A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl Cancer Inst. 51, 1409-1413.
100. Tiemann, U., and Tuchscherer, A. (1995). Effect of organochlorine pesticides on the DNA synthesis of cultured uterine cells in bovine. Biol. Reprod. 52(Suppl. 1), 170. [Abstract 453]
101. Toniolo, P. G., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K. L., Shore, R. E., Strax, P., and Pasternack, B. S. (1995). A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J. Natl. Cancer Inst. 78, 190-197.
102. Welshons, W. V., Rottinghaus, G. E., Nonneman, D. J., Dolan-Timpe, M., and Ross, P. F. (1990). A sensitive bioassay for detection of dietary estrogens in animal feeds. J. Vet. Diagn. Invest. 2, 268-273.
103. White, R., Jobling, S., Hoare, S. A., Sumpter, J. P., and Parker, M. G. (1994). Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology 135, 175-182.
104. Zacharewski, T. R., Berhane, K., and Gillesby, B., Burnison, B. K. (1995). Detection of estrogen-and dioxin-like activity in pulp and paper mill black liquor and effluent using in vitro recombinant receptor/reporter gene assays. Environ. Sci. Technol. 29, 2140-2146.
105. Zysk, J. R., Johnson, B., Ozenberger, B. A., Bingham, B., and Gorski, J. (1995). Selective uptake of estrogenic compounds by Saccharomyces cerevisiae: A mechanism for antiestrogen resistance in yeast expressing the mammalian estrogen receptor. Endocrinology 136, 1323-1326.